Molecule Details
InChIKeyFLNYCRJBCNNHRH-OIYLJQICSA-N
Compound NameSerlopitant
Canonical SMILESC[C@@H](O[C@H]1CC[C@@H]2CN(C3=CC(=O)CC3)C[C@H]2[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL8.79
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB12973
Drug NameSerlopitant
CAS Number860642-69-9
Groups investigational
ATC Codes nan
DescriptionSerlopitant has been investigated for the treatment of Prurigo Nodularis.
Categories: Heterocyclic Compounds, Fused-Ring Neurokinin-1 Receptor Antagonists Neurotransmitter Agents
Cross-references: BindingDB: 50277511 CHEMBL447955 ChemSpider: 24686685 PubChem:23653789 PubChem:347829113 Wikipedia: Serlopitant
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P25103 TACR1 Homo sapiens Human PF00001 9.1 IC50 ChEMBL;BindingDB
P21452 TACR2 Homo sapiens Human PF00001 8.6 Ki ChEMBL;BindingDB
P29371 TACR3 Homo sapiens Human PF00001 8.6 Ki ChEMBL;BindingDB
DrugBank Target Actions (1)
Target Gene Target Name Action Type
P25103 TACR1 Substance-P receptor antagonist targets